A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)
Clinical trial NCT06864169 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06864169
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2026-08-18
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.